Summary & Overview
CPT 53865: Cystoscopic Prostatic Urethral Compression Device Placement
CPT code 53865 represents a minimally invasive cystoscopic procedure that places a temporary device into the prostatic urethra to compress tissue and induce ischemia, aiming to relieve urethral obstruction and improve urinary flow. This code captures a targeted endoscopic approach used in select patients with prostatic-related lower urinary tract symptoms; nationally, its use factors into procedural coding, coverage determinations, and outpatient surgical workflows.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and service context, an outline of payer coverage considerations, and guidance on where to look for benchmarks and policy updates. The material addresses typical sites of service (ambulatory surgical centers and hospital outpatient departments) and the procedural nature of the service, useful for coding staff, billing analysts, and clinical program managers.
This publication provides an executive-level summary of the code’s purpose and operational setting, summarizes what clinicians and coders should know about reporting the service, and identifies areas where readers may need to consult payer-specific policies or clinical guidelines. Data not available in the input.
Billing Code Overview
CPT code 53865 describes a cystoscopic procedure in which a temporary implantable device is placed into the portion of the urethra that traverses the prostate. The device compresses prostatic tissue to induce focal ischemia, with the clinical intent of reducing urethral obstruction and improving urinary flow.
-
Service type: Minimally invasive endoscopic prostatic urethral compression procedure
-
Typical site of service: Ambulatory surgical center or hospital outpatient department
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a man in his 60s–80s presenting with progressive lower urinary tract symptoms (urinary frequency, weak stream, nocturia, incomplete emptying) attributable to benign prostatic hyperplasia (BPH). After urologic evaluation including history, physical exam with digital rectal exam, urinalysis, serum creatinine, and prostate-specific antigen as indicated, the provider discusses minimally invasive options. The patient elects transurethral insertion of a temporary prostatic urethral device delivered via cystoscope that compresses prostatic tissue to induce ischemic remodeling and improve urine flow. The procedure is typically performed in an ambulatory surgery center or hospital outpatient department under monitored anesthesia care or general anesthesia. Peri-procedural workflow includes pre-procedure consent and counseling, cystoscopic insertion of the device (CPT 53865), observation for urinary retention or hematuria, short recovery and discharge with post-procedure instructions and planned follow-up for device removal or assessment of symptom improvement.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / default | Rarely reported; used where payer requires a default two-character modifier but typically not appended |